Login

Clearside Biomedical, Inc. 3 SEC Filings

Filed On Filing
16 Apr 2024 Form 3: Gibney Anthony S, Director

No securities owned

18 Mar 2024 Form 3: Chong Ngai Hang Victor, CHIEF MEDICAL OFFICER

No securities owned

01 Nov 2023 Form 3: Whitmore Bradford T, 10% owner

Holds 3,914,812 shares of Common Stock

04 Mar 2022 Form 3: Yerxa Benjamin R, Director

Holds 10,144 shares of Common Stock

26 Jun 2020 Form 3: Ciulla Thomas, Chief Medical Officer

Holds 145,000 shares of Common Stock

23 Apr 2020 Form 3: Hutson Nancy J, Director

No securities owned

26 Nov 2019 Form 3: Whitmore Bradford T, 10% owner

Holds 2,600,000 shares of Common Stock

28 Sep 2018 Form 3: Edwards Jeffrey L, Director

No securities owned

27 Feb 2018 Form 3: Raymond Brion S., Chief Commercial Officer

No securities owned

10 Aug 2017 Form 3: Lasezkay George M, Director

No securities owned

13 Jun 2016 Form 3: Cormorant Asset Management, Llc, 10% owner and 3 others

Holds 1,988,208 shares of Common Stock

01 Jun 2016 Form 3: Zaytsev Evgeny, Director

No securities owned

01 Jun 2016 Form 3: Yoon Derek, Director

No securities owned

01 Jun 2016 Form 3: White Daniel H., Director

Holds 463,645 shares of Common Stock

01 Jun 2016 Form 3: Thorp Clay, Director

Holds 112,048 shares of Common Stock

01 Jun 2016 Form 3: Shaffer Christy L, Director

No securities owned

01 Jun 2016 Form 3: Rmi Investments S.a.r.l., 10% owner and 1 other

Holds 335,769 shares of Common Stock

01 Jun 2016 Form 3: Noronha Glenn, Executive Vice President, R&D
01 Jun 2016 Form 3: Humphries William D., Director
01 Jun 2016 Form 3: Hatteras Venture Advisors Iv SBIC, Llc, 10% owner and 6 others

Holds 56,025 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support